Revenue
$8.3M
▼ 71.6% YoY
Net Income
-$299.8M
▼ 74.3% YoY
EPS
$-0.54
▼ 125.0% YoY
Cash
$1.4B
▼ 47.7% YoY
FY 2026 · As of 2026-03-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Venker Eric President & Immunovant CEO | Vest | May 22, 2026 | 200.0K | $3.85 | $770K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell | May 22, 2026 | 200.0K | $30.27 | $6.05M | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell tax | May 20, 2026 | 34.5K | $32.41 | $1.12M | Form 4 ↗ |
Pulik Richard CFO | Sell tax | May 20, 2026 | 19.0K | $32.41 | $615K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Vest | Apr 20, 2026 | 200.0K | $3.85 | $770K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell | Apr 20, 2026 | 200.0K | $29.59 | $5.92M | Form 4 ↗ |
Pulik Richard CFO | Grant | Apr 20, 2026 | 60.6K | $0.00 | $0 | Form 4 ↗ |
Humes Jennifer Chief Accounting Officer | Grant | Apr 20, 2026 | 29.2K | $0.00 | $0 | Form 4 ↗ |
Oren Ilan Insider | Grant | Apr 17, 2026 | 896 | $0.00 | $0 | Form 4 ↗ |
Oren Ilan Insider | Sell tax | Apr 17, 2026 | 95 | $29.83 | $3K | Form 4 ↗ |
Epperly Melissa B, Director | Grant | Apr 17, 2026 | 670 | $0.00 | $0 | Form 4 ↗ |
MOMTAZEE JAMES C Director | Grant | Apr 17, 2026 | 469 | $0.00 | $0 | Form 4 ↗ |
MOMTAZEE JAMES C Director | Sell tax | Apr 17, 2026 | 94 | $29.83 | $3K | Form 4 ↗ |
Gline Matthew CEO | Sell | Apr 16, 2026 | 289.8K | $29.16 | $8.45M | Form 4 ↗ |
Humes Jennifer Chief Accounting Officer | Sell | Apr 8, 2026 | 13.5K | $28.37 | $384K | Form 4 ↗ |
Torti Frank President and Vant Chair | Sell tax | Mar 31, 2026 | 160.0K | $27.70 | $4.43M | Form 4 ↗ |
Gline Matthew CEO | Sell tax | Mar 31, 2026 | 304.7K | $27.70 | $8.44M | Form 4 ↗ |
Gline Matthew CEO | Vest | Mar 30, 2026 | 97.3K | - | - | Form 4 ↗ |
Gline Matthew CEO | Sell tax | Mar 30, 2026 | 53.8K | $26.41 | $1.42M | Form 4 ↗ |